JPRN-UMIN000008610
Completed
未知
To clarify different effects of daily and weekly hPTH(1-34), teriparatide, administration on local and systemic bone metabolism during healing period after vertebral fracture. - To test different effects of daily and weekly teriparatide on local and systemic bone metabolism during fracture healing after vertebral fracture
Conditionsosteoporosis
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- osteoporosis
- Sponsor
- Saitama Medical University
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Patients in whom study drugs (teriparatide) are contraindicated 2\. Serious renal, hepatic, or cardiac disease 3\. Secondly osteoporosis 4\. Patients who are considered inappropriate for enrollment by the investigator for any other reason
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Effect of a weekly vs. daily changing interval on the contamination of anesthesia breathing circuits with bacteria and viruses.Contamination of anaesthesia breathing circuits with pathogensDRKS00007717Sektion Krankenhaus- und Umwelthygiene des Uniklinikums Heidelberg
Active, not recruiting
Not Applicable
Effects and comparisons of once & twice daily insulin’s in combination with oral hypoglycaemic agents on glycaemic control, hypoglycaemia and weight in type 2 Diabetes.Type 2 DiabetesMedDRA version: 8.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusEUCTR2005-003824-21-GBRoyal Liverpool University Hospital
Completed
Not Applicable
Investigation of the relationship between daily vital data, lifestyle habits and brain health indicatorsJPRN-UMIN000048910Panasonic Holdings Corporation56
Completed
Phase 2
Comparison of the effect of single and twice daily administration of ranitidine in relief of morning abdominal pain and nausea in childreabdominal pain and nausea.Unspecified abdominal painIRCT20171211037830N2Deputy of Research of Golestan University of Medical Sciences150
Completed
Phase 4
Daily single-strength vs. thrice-weekly double-strength trimethoprim/ sulfamethoxazole for Pneumocystis jirovecii prophylaxis in kidney transplant recipients: A non-inferiority randomized control trialrenal transplantliver transplantheart transplantcotrimoxazolebactrimPneumocystisTransplant RecipientsTCTR20240329004/A65